S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73% Market Closed
Market Cap: 20.1m EUR

Surgalign Holdings Inc
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Surgalign Holdings Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgalign Holdings Inc
F:RT2
Net Change in Cash
-$22.2m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
-10%
Haemonetics Corp
NYSE:HAE
Net Change in Cash
-$2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
21%
ICU Medical Inc
NASDAQ:ICUI
Net Change in Cash
-$12.8m
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Change in Cash
-$37.2m
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Change in Cash
-$484.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-56%
Merit Medical Systems Inc
NASDAQ:MMSI
Net Change in Cash
-$130.7m
CAGR 3-Years
-104%
CAGR 5-Years
N/A
CAGR 10-Years
-69%
No Stocks Found

Surgalign Holdings Inc
Glance View

Market Cap
20.1m EUR
Industry
Health Care

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.

RT2 Intrinsic Value
Not Available
S

See Also

What is Surgalign Holdings Inc's Net Change in Cash?
Net Change in Cash
-22.2m USD

Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Net Change in Cash amounts to -22.2m USD.

What is Surgalign Holdings Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-10%

Over the last year, the Net Change in Cash growth was -17%.

Back to Top